Ardelyx’s (ARDX) “Buy” Rating Reiterated at LADENBURG THALM/SH SH
LADENBURG THALM/SH SH reissued their buy rating on shares of Ardelyx (NASDAQ:ARDX – Free Report) in a research report sent to investors on Friday, Marketbeat reports. The brokerage currently has a $11.00 target price on the biopharmaceutical company’s stock. Several other equities research analysts also recently weighed in on ARDX. Cantor Fitzgerald raised Ardelyx to […]
LADENBURG THALM/SH SH reissued their buy rating on shares of Ardelyx (NASDAQ:ARDX – Free Report) in a research report sent to investors on Friday, Marketbeat reports. The brokerage currently has a $11.00 target price on the biopharmaceutical company’s stock. Several other equities research analysts also recently weighed in on ARDX. Cantor Fitzgerald raised Ardelyx to […]
